Product Program year 2025 Source: CMS Open Payments

Resolute Onyx

Device Stents

PDI 00643169556997

Open in the dashboard

General payments

$1,906,944

14,322 payments

Research payments

$799,251

219 payments

Through program year 2025, $1,906,944 in general payments and $799,251 in research payments were reported against Resolute Onyx (Stents).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

8 rows
Year Kind Amount Payments
2025 General $64,292 593
2025 Research $65,662 40
2024 General $195,648 978
2024 Research $89,837 48
2023 General $366,561 2,313
2023 Research $344,486 87
2022 General $1,280,443 10,438
2022 Research $299,265 44

Breakdown

Who paid General payments · program years 2022–2025
  1. Medtronic, Inc. $1,906,944 14,322 payments
Top recipients General payments · program year 2025
  1. Shailendra Singh Interventional Cardiology · Allentown, PA $3,038 5% · 10 payments
  2. Florian Rader Cardiovascular Disease · West Hollywood, CA $2,853 4% · 20 payments
  3. Rhian Davies Cardiovascular Disease · York, PA $2,517 4% · 12 payments
  4. Kathleen Kearney Interventional Cardiology · Seattle, WA $2,015 3% · 10 payments
  5. Leah Raj Interventional Cardiology · Nashville, TN $1,946 3% · 15 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Interventional Cardiology Internal Medicine $22,706 43% · 88 practitioners
  2. Cardiovascular Disease Internal Medicine $15,627 30% · 64 practitioners
  3. Internal Medicine $9,200 17% · 51 practitioners
  4. Hospitalist $3,405 6% · 19 practitioners
  5. Nurse Practitioner $386 <1% · 4 practitioners

The top 5 of 18 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Pennsylvania $8,208 13% · 24 recipients
  2. California $4,920 8% · 14 recipients
  3. Missouri $4,453 7% · 24 recipients
  4. Massachusetts $3,811 6% · 20 recipients
  5. Kansas $3,658 6% · 29 recipients

The top 5 of 43 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

14,322 general · 219 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record